Share on StockTwits

Examworks Group (NASDAQ:EXAM) Chairman Richard E. Perlman sold 939,025 shares of the company’s stock on the open market in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $32.30, for a total transaction of $30,330,507.50. Following the completion of the sale, the chairman now directly owns 647,827 shares of the company’s stock, valued at approximately $20,924,812. The sale was disclosed in a document filed with the SEC, which is available at this link.

Examworks Group (NASDAQ:EXAM) remained flat at $31.17 during trading on Thursday. 381,501 shares of the company’s stock traded hands. Examworks Group has a 52 week low of $17.98 and a 52 week high of $38.61. The stock has a 50-day moving average of $35.19 and a 200-day moving average of $31.64. The company’s market cap is $1.201 billion.

Examworks Group (NASDAQ:EXAM) last released its earnings data on Tuesday, May 6th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.02. The company had revenue of $173.00 million for the quarter, compared to the consensus estimate of $166.64 million. During the same quarter in the previous year, the company posted ($0.10) earnings per share. The company’s revenue for the quarter was up 16.3% on a year-over-year basis. Analysts expect that Examworks Group will post $0.18 EPS for the current fiscal year.

EXAM has been the subject of a number of recent research reports. Analysts at Needham & Company LLC raised their price target on shares of Examworks Group from $39.00 to $43.00 in a research note on Wednesday, May 7th. They now have a “buy” rating on the stock. Separately, analysts at Zacks upgraded shares of Examworks Group from a “neutral” rating to an “outperform” rating in a research note on Wednesday, April 30th. They now have a $40.70 price target on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Examworks Group from $37.00 to $41.00 in a research note on Monday, April 21st. They now have an “outperform” rating on the stock.

ExamWorks Group, Inc (NASDAQ:EXAM) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, referred to as IME services or the IME industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.